Ticilimumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ticilimumab, covering 2012-06-07 to 2020-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma [Phase 2]